'Plan-B':  Impact of changes in the global funding landscape for Hepatitis B clinical and research programmes
We are a team of clinicians and researchers based at the Francis Crick Institute in London, and working with international partners and collaborators to advance progress towards hepatitis B elimination.

We are gathering experiences and insights into the impact of the federal funding changes on hepatitis B programmes worldwide as a result of the new US government since January 2025.

We are asking for feedback from anyone who has lived experience, or is working in the hepatitis B field, in any role including clinical, research/academia, public health, policy, teaching, industry or civil society. Please take a few minutes to populate this form (a few tick box questions and then an opportunity to send free text).

We will be hosting a hybrid meeting of a multidisciplinary network ('HBV-CARE') in June at the Crick to discuss the feedback, with the aim of generating a report and considering action steps for the international community working in this field. 

If you provide us with your contact details,  we will keep you involved in this process as we work towards next steps. We will still keep any specific feedback anonymous and confidential (it will be shared without your name and we will redact details of specific organisations). 

You are also welcome to provide feedback anonymously or by email if you prefer.

More details:
Direct email contact: philippa.matthews@crick.ac.uk / marion.delphin@crick.ac.uk
Bluesky: @pippa-matt.bsky.social
Website for more information about our team: https://www.crick.ac.uk/research/labs/philippa-matthews
More information about HBV-CARE: https://doi.org/10.6084/m9.figshare.c.6396434
Registration link for HBV-CARE meeting (12 June 2025): https://www.eventbrite.fr/e/hbv-care-2025-tickets-1280998654459?aff=oddtdtcreator

Sign in to Google to save your progress. Learn more
Please let us know your roles (select all that apply)
Please let us know where in the world you have experience of the HBV landscape (select all that apply).
Since changes in the US political and funding landscape in January 2025, please select one option which best describes how you see changes in access to HBV diagnosis, clinical care and treatment:
Clear selection
Since changes in the US political and funding landscape in January 2025, please describe one option which best describes how you see changes in funding for HBV clinical, implementation and basic science research
Clear selection
How concerned do you feel about the future impact of policy and funding changes with respect to delivery of HBV diagnosis, clinical care and treatment
Clear selection
How concerned do you feel about the future impact of policy and funding changes with respect to clinical and basic science research relating to hepatitis B
Clear selection
Please tell us about your personal experiences with respect to the impact of political and funding changes on hepatitis B in the setting(s) where you work. You can also provide details explaining your answers to the above questions. 

Your answer will be shared with a group working to raise awareness and tackle problems. Individual answers will be treated in confidence, not shared more widely without your permission, and identifying details will be removed to protect anonymity as far as possible. 
Are there any other questions we should include for specific consideration as we collate feedback?
If you would like us to stay in touch with updates and shared responses, please provide your email address. You can leave this blank if you prefer not to be contacted. 
Submit
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. - Terms of Service - Privacy Policy

Does this form look suspicious? Report

Google Forms